Growth hormone (GH) or insulin-like growth factor (IGF)-I represses 11β-hydroxysteroid dehydrogenase type 1 (HSD1) mRNA expression in 3T3-L1 cells and its activity in their homogenates

Endocrine Journal

Volumn 56, Issue 4, 2009, Pages 561-570

  Morita, Junko ^a   Hakuno, Fumihiko ^b   Hizuka, Naomi ^a   Takahashi, Shin Ichiro ^b   Takano, Kazue ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

11 hydroxysteroid dehydrogenase type 1 (11 HSD1); Adipocytes; Growth hormone (GH); Insulin like growth factor I (IGF I)

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; GROWTH HORMONE; MESSENGER RNA; SOMATOMEDIN C;

ADIPOGENESIS; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL FREE SYSTEM; CELL STRAIN 3T3; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION REGULATION; HORMONE ACTION; MOUSE; NONHUMAN; PROADIPOCYTE;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 2; 3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CELL DIFFERENTIATION; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MICE; RNA, MESSENGER;

EID: 68449099560     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.K08E-311     Document Type: Article

References (23)

1. th ed. Williams Textbook of endocrinology, Saunders, Philadelphia. Chap. 8:180-235
2. Gelding SV, Taylor NF, Wood PJ, Noonan K, Weaver JU, Wood DF, Monson JP. (1998) The effect of growth hormone replacement therapy on cortisol-cortisone interconversion in hypopituitary adults: evidence for growth hormone modulation of extrarenal 11β-hydroxysteroid dehydrogenase activity. Clin Endocrinol (Oxf). 48:153-162 (Pubitemid 28091045)
3. Moore JS, Monson JP, Kaltsas G, Putignano P, Wood PJ, Sheppard MC, Besser GM, Taylor NF, Stewart PM. (1999) Modulation of 11β-hydroxysteroid dehydrogenase isozymes by growth hormone and insulin-like growth factor: in vivo and in vitro studies. J Clin Endocrinol Metab. 84:4172-4177 (Pubitemid 30644213)
4. Jamieson PM, Chapman KE, Edwards CR, Seckl JR. (1995) 11β-hydroxysteroid dehydrogenase is an exclusive 11β-reductase in primary cultures of rat hepatocytes: effect of physicochemical and hormonal manipulations. Endocrinology. 136:4754-4761
5. Draper N, Stewart PM. (2005) 11β-hydroxysteroid dehydrogenase and the pre-receptor regulation of corticosteroid hormone action. J Endocrinol. 186:251-271 (Pubitemid 41167396)
6. Stewart PM, Murry BA, Mason JI. (1994) Human kidney 11β- hydroxysteroid dehydrogenase is a high affinity nicotinamide adenine dinucleotide-dependent enzyme and differs from the cloned type I isoform. J Clin Endocrinol Metab. 79:480-484 (Pubitemid 2127090)
7. Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS. (2001) A transgenic model of visceral obesity and the metabolic syndrome. Science. 294:2166-2170 (Pubitemid 33150673)
8. Napolitano A, Voice MW, Edwards CR, Seckl JR, Chapman KE. (1998) 11β-hydroxysteroid dehydrogenase 1 in adipocytes: expression is differentiation-dependent and hormonally regulated. J Steroid Biochem Mol Biol. 64:251-260 (Pubitemid 28221628)
9. Ozols J. (1995) Lumenal orientation and posttranslational modifications of the liver microsomal 11β-hydroxysteroid dehydrogenase. J Biol Chem. 270:10360.
10. Bujalska IJ, Kumar S, Stewart PM. (1997) Does central obesity reflect "Cushing's disease of the omentum"? Lancet. 349 :1210-1213
11. Tomlinson JW, Sinha B, Bujalska I, Hewison M, Stewart PM. (2002) Expression of 11β-hydroxysteroid dehydrogenase type 1 in adipose tissue is not increased in human obesity. J Clin Endocrinol Metab. 87:5630-5635 (Pubitemid 36034370)
12. Gout J, Tirard J, Thevenon C, Riou JP, Begeot M, Naville D. (2006) CCAAT/enhancer-binding proteins (C/EBPs) regulate the basal and cAMP-induced transcription of the human 11β-hydroxysteroid dehydrogenase encoding gene in adipose cells. Biochimie. 88:1115-1124 (Pubitemid 44415208)
13. Kim J, Temple KA, Jones SA, Meredith KN, Basko JL, Brady MJ. (2007) Differential modulation of 3T3-L1 adipogenesis mediated by 11β- hydroxysteroid dehydrogenase- 1 levels. J Biol Chem. 282:11038-11046 (Pubitemid 47100791)
14. Smith PJ, Wise LS, Berkowitz R, Wan C, Rubin CS. (1988) Insulin-like growth factor-I is an essential regu lator of the differentiation of 3T3-L1 adipocytes. J Biol Chem. 263:9402-9408 (Pubitemid 18160219)
15. Balachandran A, Guan H, Sellan M, van Uum S, Yang K. (2008) Insulin and dexamethasone dynamically regulate adipocyte 11β-hydroxysteroid dehydrogenase type 1. Endocrinology. 149:4069-4079
16. Slavin BG, Ong JM, Kern PA. (1994) Hormonal regulation of hormone-sensitive lipase activity and mRNA levels in isolated rat adipocytes. J Lipid Res. 35:1535-1541
17. Fleenor D, Arumugam R, Freemark M. (2006) Growth hormone and prolactin receptors in adipogenesis: STAT-5 activation, suppressors of cytokine signaling, and regulation of insulin-like growth factor I. Horm Res. 66:101-110 (Pubitemid 44213993)
18. Tomlinson JW, Walker EA, Bujalska IJ, Draper N, Lavery GG, Cooper MS, Hewison M, Stewart PM. (2004) 11β-hydroxysteroid dehydrogenase type 1: a tissue-specific regulator of glucocorticoid response. Endocr Rev. 25:831-866 (Pubitemid 39366049)
19. Lavery GG, Walker EA, Draper N, Jeyasuria P, Marcos J, Shackleton CH, Parker KL, White PC, Stewart PM. (2006) Hexose-6-phosphate dehydrogenase knockout mice lack 11β-hydroxysteroid dehydrogenase type 1-mediated glucocorticoid generation. J Biol Chem. 281:6546-6551 (Pubitemid 43847588)
20. Mason PJ, Stevens D, Diez A, Knight SW, Scopes DA, Vulliamy TJ. (1999) Human hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) encoded at 1p36: coding sequence and expression. Blood Cells Mol Dis. 25:30-37 (Pubitemid 29205488)
21. Atanasov AG, Nashev LG, Schweizer RA, Frick C, Odermatt A. (2004) Hexose-6-phosphate dehydrogenase determines the reaction direction of 11β- hydroxysteroid dehydrogenase type 1 as an oxoreductase. FEBS Lett. 571:129-133 (Pubitemid 38992936)
22. Frajese GV, Taylor NF, Jenkins PJ, Besser GM, Monson JP. (2004) Modulation of cortisol metabolism during treatment of acromegaly is independent of body composition and insulin sensitivity. Horm Res. 61:246-251
23. Rosenbaum M, Gertner JM, Leibel RL. (1989) Effects of systemic growth hormone (GH) administration on regional adipose tissue distribution and metabolism in GH-deficient children. J Clin Endocrinol Metab. 69:1274-1281 (Pubitemid 20010059)